Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-09

Clinical Trial Update: Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating induced hypertension with peripherally diluted norepinephrine for acute ischemic stroke; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Stroke, Acute, Stroke, Ischemic | Phase 3 | Status: RECRUITING